BIOVIE INC.
Develops drug therapies for neurological disorders and advanced liver disease.
BIVI | US
Overview
Corporate Details
- ISIN(s):
- US09074F4054
- LEI:
- Country:
- United States of America
- Address:
- 680 W NYE LANE, 89703 CARSON CITY
- Website:
- https://www.bioviepharma.com/
- Sector:
- Manufacturing
Description
BioVie Inc. is a clinical-stage biopharmaceutical company that develops drug therapies for chronic debilitating conditions. The company's pipeline focuses on neurological and neurodegenerative disorders as well as advanced liver disease. Its lead drug candidate, bezisterim, is being studied for Alzheimer's disease based on the hypothesis that modulating inflammation and enhancing insulin sensitivity in the brain can improve cognitive function and provide neuroprotection. Other areas of focus include Parkinson's disease, ascites (a common complication of advanced liver cirrhosis), and Long COVID. The company also conducts research into epigenetic mechanisms, such as DNA methylation, to understand gene expression regulation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BIOVIE INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIOVIE INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIOVIE INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
